Effect of Diaphragmatic Myofascial Release on Thoracic Angle and Pulmonary Functions in Hyperkyphotic Adolescents

May 21, 2024 updated by: Amira Hussin Hussin Mohammed, Delta University for Science and Technology

Effect of Diaphragmatic Myofascial Release on Thoracic Curvature Angle and Pulmonary Functions in Hyperkyphotic Adolescents

Adolescent kyphotic girls will participate in this study. They will be divided into two groups. Group A: The control group will receive a therapeutic exercise program. Group B: The study group will receive the same intervention as Group A in addition to diaphragmatic myofascial release. They will be assessed at baseline and after three successive months of interventions for the following outcomes: Cobb angle by x-ray and pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) by computerized spirometer

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Adolescent kyphotic girls with an age range of 12-15 years old will participate in this study. They will be divided into two groups. Group A: The control group will receive a therapeutic exercise program. Group B: The study group will receive the same intervention as Group A in addition to diaphragmatic myofascial release. Both groupss will receive intervention for three three successive months. They will be be assessed at baseline and after three three successive months of interventions for the following outcomes:

Primary outcome: Cobb angle by x-ray Secondary outcome: pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) by computerized spirometer

Study Type

Interventional

Enrollment (Actual)

102

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Egypt
      • Gamasa, Egypt, 35712
        • Amira Hussin Mohammed

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

13 years to 16 years (Child)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Adolescents girls with thoracic kyphosis with cobb angle ranged from 45 to 55 degree.
  • Age ranged from 12 to 15 years old.
  • selected from preparatory and secondary schools.

Exclusion Criteria:

  • free from any associated deformities other than the thoracic kyphotic deformity.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: study Group (B)
study group will received the same intervention in control group in addition to diaphragmatic myofascial release (3 sessions/week/two months).
Other: therapeutic exercise program
therapeutic exercise program (3 sessions/week/two months).
Other: diaphragmatic myofascial release
therapeutic exercise program in addition to diaphragmatic myofascial release (3 sessions/week/two months).
Experimental: Control group (A)
The control group will receive a therapeutic exercise program (3 sessions per week for two months).
Other: therapeutic exercise program
therapeutic exercise program (3 sessions/week/two months).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cobb angle
Time Frame: Change from Cobb angle at 3 months
Cobb angle by x-ray
Change from Cobb angle at 3 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume)
Time Frame: Change from pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) at 2 months
pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) by computerized spirometer
Change from pulmonary functions (vital capacity, forced vital capacity and maximum ventilatory volume) at 2 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Delta University for Science and Technology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 25, 2022

Primary Completion (Actual)

May 30, 2023

Study Completion (Actual)

May 30, 2023

Study Registration Dates

First Submitted

February 6, 2023

First Submitted That Met QC Criteria

February 14, 2023

First Posted (Actual)

February 16, 2023

Study Record Updates

Last Update Posted (Actual)

May 22, 2024

Last Update Submitted That Met QC Criteria

May 21, 2024

Last Verified

May 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • diaphragm myofascial release

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Adolescent Kyphosis

Clinical Trials on therapeutic exercise program

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe